Scopus Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in Scopus. This abstract is what is used to create the fingerprint of the publication.
Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis
Y.-P. Mei; J.-P. Liao; J. Shen; L. Yu; B.-L. Liu; L. Liu; R.-Y. Li; L. Ji; S.G. Dorsey; Z.-R. Jiang; et al. (Profiled Authors: Lin Ji; Ruth L Katz)
Oncogene. 2012;31(22):2794-2804.
AbstractNon-small cell lung cancer (NSCLC) is the leading cause of cancer death, reflecting the need for better understanding the oncogenesis, and developing new diagnostic and therapeutic targets for the malignancy. Emerging evidence suggests that small nucleolar RNAs (snoRNAs) have malfunctioning roles in tumorigenesis. Our recent study demonstrated that small nucleolar RNA 42 (SNORA42) was overexpressed in lung tumors. Here, we investigate the role of SNORA42 in tumorigenesis of NSCLC. We simultaneously assess genomic dosages and expression levels of SNORA42 and its host gene, KIAA0907, in 10 NSCLC cell lines and a human bronchial epithelial cell line. We then determine in vitro functional significance of SNORA42 in lung cancer cell lines through gain-and loss-of-function analyses. We also inoculate cancer cells with SNORA42-siRNA into mice through either tail vein or subcutaneous injection. We finally evaluate expression level of SNORA42 on frozen surgically resected lung tumor tissues of 64 patients with stage I NSCLC by using quantitative reverse transcriptase PCR assay. Genomic amplification and associated high expression of SNORA42 rather than KIAA0907 are frequently observed in lung cancer cells, suggesting that SNORA42 overexpression is activated by its genomic amplification. SNORA42 knockdown in NSCLC cells inhibits in vitro and in vivo tumorigenicity, whereas enforced SNORA42 expression in bronchial epitheliums increases cell growth and colony formation. Such pleiotropy of SNORA42 suppression could be achieved at least partially through increased apoptosis of NSCLC cells in a p53-dependent manner. SNORA42 expression in lung tumor tissue specimens is inversely correlated with survival of NSCLC patients. Therefore, SNORA42 activation could have an oncogenic role in lung tumorigenesis and provide potential diagnostic and therapeutic targets for the malignancy. © 2012 Macmillan Publishers Limited All rights reserved.
PMID: 21986946
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2009Jong K. Woo; Soon Choi Dong; Hai T. Tran; Brian E. Gilbert; Ki Hong Waun; Ho-Young Lee
Cancer Prevention Research. 2009;2(4):361-369. -
2.
2006Raju V. Pusapati; Robert J. Rounbehler; SungKi Hong; John T. Powers; Mingshan Yan; Kaoru Kiguchi; Mark J. McArthur; Paul K. Wong; David G. Johnson
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc
Proceedings of the National Academy of Sciences of the United States of America. 2006;103(5):1446-1451. -
3.
2010Salvador Vázquez-Vega; Adriana Contreras-Paredes; Marcela Lizano-Soberón; Alfredo Amador-Molina; Alejandro García-Carrancá; Lilia Patricia Sánchez-Suárez; Luis Benítez-Bribiesca
RNA interference (RNAi) and its therapeutic potential in cancer
Revista de Investigacion Clinica. 2010;62(1):81-90.
Related Topics
Appears in this Document
Related Experts
Author of this Document
-
Internal ExpertsPublications
-
589









-
589









-
63









-
310









-
183









-
361












